Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Work for nothing and you'll always be busy.
Does anyone else feel with the right CEO and industry connections VAL could fly?
That Theorem website gets worse with every development. They can't even update Dodgy Ken's profile pic with one that's in focus. Absolutely bobbins.
They will be looking at Ovarian according to the latest RNS. On Trx website that is an area they are specializing in too. The plot thickens....
The market cap of EUDA is 40 million dollars based on what exactly? IF it was 10 USD without dilution it would be valued at 300 million dollars. We are not looking at the share price of EUDA but market cap.
It was not the evaluation period of the merger but purely for due diligence. LEARN TO READ.
TRX would have raised cash which is why they are at this stage. It took time due to the other compounds and raising additional money.
The only part that matters is getting money owed to us and get 201 progressed.
1. SP of EUDA over a year is down from 10 USD to 1.60 USD. It has to remain over 1.45 USD otherwise it gets delisted. It’s bouncing around that price on VERY low volume by traders.
2 The evaluation period of the merger finished last year and was not nor did they mention in the subsequent update that talks were ongoing, they don’t need to advise the market further.
3. Confidence in the BOD regarding the handling of 201 is shot due to the appalling way it’s been handled. I’m not even going to list all the blunders, it’s been covered to death.
4. granted that THX would benefit merging with EUDA but EUDA could find a much better suitor. It’s been discussed to death; even as a merged entity THX would need to go on and try and raise cash with no guarantees. Any new legal entity created would need to renegotiate terms regarding the LOI from back in 2021 anyhow and finally as again already discussed the tech from 201 now being over 15 years old has likely been superseded anyhow not to mention it needs reformulating and a new patent as the last set of patents expired last year.
As per usual @PM2022 you are posting utter cack
First time for everything I suppose ;-)
Certainly hope you are correct my friend!
I heard it would likely be soon without a timeline given but not going to say my source. Pure guess but I think this month but either way it should not be far.
When, in your opinion do you think Euda/Trx merger will finish Pm? I think that is key, if that goes ahead 201 will get signed in my opinion. It's just all if's and but's until then though.
201 is needed for a higher share price and lower dilution in the future plus the extra money and milestones will attract investors. Otherwise you will be raising less money due to the market cap most likely at a lower price which would be risky moving forward.
The damage is done so now if it is close to completed then no question that is what should be done. It can reverse to the 15/20p mark with 201 and come lab contracts rather than a 2p or less placing in the future.
Adams posted on Twitter about 3 times in an hour about how amazing this RNS is. So, think he likes it haha.
NH...totally agree mate ..
The TheoremRx debacle has been a farce with SD continuing with it when I've said call a day after 3 years of trying to raise..maybe she's still confident and may well surprise us then this board may review their opinions.. its revenue which will drive the SP here and currently there's none
Along with all the secrecy of not naming the Japanese Co.and others it remains a guessing game .. I think clarity would help the company but everything's a secret ...At the moment a conclusion to theoremrx is the only thing to move us significantly. We wait in hope ..
Regards the req notice I'm.not sure about the role of observer by Ron .
Is this really going to help us ..an acting Headmaster and an extra wage we don't need... The patent guy was a good call. To be honest AH role as shareholder liaison was a waste of space and did what.. another role created where his actual knowledge and profession would have been far greater used if he was employed in a role in his field and able to contribute significantly. .
PJ
Pj, I'm of the opinion AIM has been f*cked by too many lifestyle CEO's pumping their SP's with any old dross over the last five years or so.
The market only responds to tangible metrics these days. Anything vaguely sounding like jam tomorrow is dismissed out of hand.
CLX and the new evaluations might make it incredibly appealing to a dynamic, commercially astute individual whom has the ambition to make a name for themselves in the Biotech sector.
Based on
1) Share price of EUDA
2) Still ongoing. IF it was a failure it would have been announced already. Mergers that complete often take months.
3) Continued confidence of BOD in 201.
4) Both EUDA and TRX need the merger to go ahead so no real reason for it to not go ahead.
'Forget Black Cat.'
So that was just broken promises and a bad idea was it?
The foundations are NOT very strong. FACT.
IF 201 is signed....if
If 401 completes....if
....about 30/40 million due to the milestones attached from the deals. (What deals? Pure fantasy guesswork)
.....a huge deal in the next two years maybe...(maybe, maybe not)
The EUDA merger looks on.... (based on?)
Anyway, with my next 10 million investment I'm going to make half a billion. If I win the Euromillions that is. Provided I buy a ticket of course.
Bit of a poisoned chalice though, isn't it?
I can't see any prestige in taking on a small and unsuccessful non- revenue generating company. These sort of lifestyle gravy trains are two a penny on the AIM. All IMO.
Are you sure you have you decimal point in the correct place for your pence/vol. dung ratio? ;-)
Hopefully, the new CEO will have a better awareness of the need to generate short term income. I'm sure that message will be relayed loud and clear during the recruitment process.
Forget Black Cat. The foundations are very strong. FACT.
If you are looking at 1/2 year investment this can go to 50/100p and i'll explain how.
IF 201 is signed it gives them more cash runway with significant milestones. Then inside the next 12 months get CLX out licensed with at least £10 million upfront payment. If 401 completes it gives a better longer term outlook.
The market cap would be about 30/40 million due to the milestones attached from the deals. Then one of these quality projects gets a huge deal in the next two years maybe 30/40 million upfront with a milestone of a few hundred million. The market moves from bear to bull and suddenly the share price is close to £1.
From 3p hold for 1/2 years and see where this goes. The EUDA merger looks on for sure so this is a game changer as the new projects will take over.
No impact to the SP at all.!
Thought we'd get a little tick up at least ... I think until the SD situation is in place and finalised regards the other members then we ain't going anywhere .
Cobalt, I think it is grossly undervalued personally, but thats what makes these bill boards interesting (different opinions) :)
3p is a joke. Grossly overvalued pile of dung.
Whatever happened to the concept of generating revenue? What happened to all the legacy products?
No. I absolutely don’t care to look
I've never offered any opinion on SD if you care to look. I'm just saying that they need an income stream and soon, and taking on work without pay is not the way to go. The track record of deadlines is truly abysmal, and while scientifically this latest RNS may be interesting, it will take time and effort which cost money they simply can't spare.
I'd rather see an update on Black Cat (you may be too young to remember the 5 million they were going to source) and on 201 (poor results on clinically insinificant numbers and static for several years since without a peer review) and some news on TheoremRx (silent since Adam was a lad) would be a lot more welcome. They need to get their priorities in order and soon.